
    
      Subjects studied on four occasions:

        1. Intravenous buprenorphine

        2. Sublingual buprenorphine

        3. Cyclosporine, then intravenous buprenorphine. Subjects then take oral cyclosporine twice
           daily, until

        4. Sublingual buprenorphine; continue oral cyclosporine twice daily for 5 days
    
  